Patient-centricity and patient diversity are challenging goals that all clinical trial sponsors seek to attain. The ever-rising cost of patient retention in clinical trials has highlighted patient engagement and the flexibility required by the industry to meet patients where they are and make clinical trial participation easier and more customized to their needs. The webinar will present two tactics employed by PPD to address these challenges.
The Patient Concierge program focuses on 24/7 1:1 support for patients throughout the duration of the trial. This is a more personalized approach than other concierge programs and enables early identification of potential barriers that patients may face when continuing with the study. Moreover, sites can focus on patient care instead of non-medical administrative tasks.
Virtual Research Coordination Centers or decentralized sites, another tactic, decrease geographic barriers to studies for participants of diverse populations, including the elderly, those living in remote areas, or ethnic minorities currently underrepresented in traditional onsite designs. The inclusion of flexible remote and televisits facilitates higher participation as it reduces the need for family/caregiver assistance, time off work and childcare assistance.
Join this webinar to learn how patient-centricity approaches like personalized support and flexible remote options enable early identification of potential barriers and facilitate higher patient participation of diverse populations.
Kathryn Dorshimer, Associate Director, Medical Communications, PPD
Kathryn Dorshimer is a pharmaceutical industry veteran with over 20 years of experience in multiple leadership positions. She has been an Associate Director at PPD for the past four years. Kathryn was an early team member of the Patient Concierge team at PPD, which addresses challenges that patients face in completing their clinical trials. Her expertise lies in helping patients, sites and caregivers navigate the complex clinical trial landscape.
Sailesh Kaura, Senior Director, Clinical Trials Contact Center, PPD
Sailesh Kaura serves as a Senior Director and leads the operations of the Clinical Trials Contact Center, which drives novel direct-2-patient and site engagement solutions. His experience spans a variety of areas in the clinical trial space, including global project management, portfolio management, operations and client relationship roles. Sailesh joined PPD in 2013, initially working in project management and eventually progressing to his current leadership role. In his current role, he provides strategic direction, leadership and management across multiple divisions and therapeutic areas by leveraging over 25 years of experience in project delivery in both CRO and pharma.
Who Should Attend?
Clinical development professionals involved in:
- Recruitment and retention
- Study design
- Trial site management
What You Will Learn
- Learn how Patient Concierge increases study participant’s engagement and decreases dropout
- Explore how Virtual Research Coordination (VRCC) can help with attracting a more diverse patient population
- Look at both offerings from the perspective of the patient, site and the sponsor
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, PPD’s capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, we serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, we apply cutting-edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.